Calling all postdocs! Join us on Sept. 25-26 in Seattle for this unique opportunity to explore careers in #immunology, #oncology and #datasciences at Fred Hutch. Food, lodging and travel are covered! Apply by July 15: https://t.co/Gzj9njlC54
Thank you indeed! Was able to learn quite a bit about #Tcell hybrid immunity from #COVID19 infection and vaccination, integrating bulk and single-cell TCR sequencing data.
Our team VISC (Vax & Immuno Stats Center) @fredhutch is seeking a Research PM with lab and/or #datascience experience to work on portfolio of collaborative projects to accelerate #HIV#TB#malaria#COVID vax development w/ biostats analysis and immunology! https://t.co/ydQhFqBX2e
Today we sent a letter to FDA with >60 signatories advocating for FDA guidance in assessing T cell responses in COVID vaccine studies. T cell immunity is likely a major player in protection from disease. We should analyze T cells (with Abs and memory B cells) across studies.
Great to see these results! Especially love this figure illustrating the relationship between VE and pseudo neuts in three large RCTs! Remarkable agreement yet still need an explanation for substantial VE even for those with low nAbs…
New work from the US Gov’t/CoVPN Biostats Team (& others): Fong et al. immune correlates analysis of a single Ad26.COV2.S dose in the ENSEMBLE vaccine efficacy trial, on medRxiv: https://t.co/RAXcqs2WAN 🧵 1/7
New work from the US Gov’t/CoVPN Biostats Team (& others): Fong et al. immune correlates analysis of a single Ad26.COV2.S dose in the ENSEMBLE vaccine efficacy trial, on medRxiv: https://t.co/RAXcqs2WAN 🧵 1/7
We're proud to be a part of the Seattle #tuberculosis research advancement center, leading the Data Science Core with @agartland to provide #bioinformatic and computational biology support and training to Seattle TB researchers.
Hiring a #DataScientist w/ curiosity + integrity to join our group @fredhutch! We work to understand human immune responses and to accelerate design of safe + effective vaccines for #tuberculosis#HIV#COVID Seeking #diversity in applicants, plz RT! https://t.co/6ZMgoGOaGx
Please help spread the word! Multiple postdoc and staff scientist positions for translational and basic science research in computational immunology in our group. Please DM or email me. See what we do https://t.co/wahwPdK3QY and our publications at https://t.co/Nc2Aor41o8
We have submitted new results to medRxiv:
Omicron infection enhances neutralizing immunity against the Delta variant
The preprint can be found here:
https://t.co/rGaEB9GdmS
We have completed our first experiments on neutralization of Omicron by Pfizer BNT162b2 vaccination elicited immunity
Manuscript available at
https://t.co/rGaEB9GdmS
and should be available on medRxiv in the coming days
Out today! We describe TCR "meta-clonotypes": analytical tool for TCR repertoire analysis + open-source software for any distance-based analysis + application to #SARSCoV2 Awesome collab with @PGTimmune@sschattgen@Liel_Cohen_@aanaishe @jeremycfd et al. https://t.co/TR1SSH8o4w
Check it out! https://t.co/92ATgNLWSa Videos, great examples, you do not need to be an expert to get the code running. Led by Koshlan Mayer-Blackwell and @agartland, with @sschattgen, @Liel_Cohen_, @jeremycfd, @aanaishe, @TomerHertz & nontweeters Phil Bradley and Jessica Gaevert
Great extension of tcrdist by @agartland and Koshlan Mayer-Blackwell for defining “meta-clonotypes” of similar TCRs from antigen-enriched repertoires. It will be an important tool for addressing the challenge of private specificity in repertoire profiling. https://t.co/t1J6yzPbK4
Please RT.
TWO (!) job openings @UCSF on TB-related projects: (1) working on novel TB vaccines in my group, (2) shared position with my fantastic colleague John Metcalfe on TB diagnostics as well as TB drug tolerance.
https://t.co/NX6KzGVfnC
https://t.co/xejDO9S8Hc